A groundbreaking study from June 2026, published in Nature Metabolism, revealed how the popular joint supplement Glucosamine is linked with a 25% faster progression from mild cognitive impairment to Alzheimer's disease.
There is also a 25% risk of mortality for those who are already diagnosed with dementia. However, a senior study author emphasized how cognitively healthy older adults have no clear signal of harm and don't need to panic.
